Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.
about
Telomeres in diseaseHow I treat acquired aplastic anemiaShort telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancyThe complex pathophysiology of acquired aplastic anaemiaModeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome EngineeringDanazol Treatment for Telomere DiseasesImmunosuppressive therapy for transplant-ineligible aplastic anemia patients.Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemiaProlonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia.The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failureEffect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemiaPeripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia.Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia.Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.Bone marrow failure and the telomeropathies.Recent advances in treatment of aplastic anemia.Shorter telomere length in peripheral blood leukocytes is associated with childhood autism.Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans.Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials NeMyelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantationTelomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia.Clinical management of aplastic anemia.Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres.Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.Human telomere disease due to disruption of the CCAAT box of the TERC promoter.Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature.Eltrombopag and improved hematopoiesis in refractory aplastic anemia.Treatment-related myelodysplastic syndrome: molecular characteristics and therapyAge-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.Acute promyelocytic leukemia transformation in a patient with aplastic anemia: a case report with literature review.Success of allogeneic marrow transplantation for children with severe aplastic anaemia.Telomere dynamics in mice and humansShort leukocyte telomere length predicts risk of diabetes in american indians: the strong heart family study.The Third Consensus Conference on the treatment of aplastic anemia.Aplastic anemia: immunosuppressive therapy in 2010.The optimal immunosuppressive therapy for aplastic anemia.
P2860
Q24606234-F926C3D7-1D39-447D-A38F-47AA6F8E7689Q24617687-F86C61CC-4C6C-4611-AA37-E32E9A2AD51EQ26852788-663EB0D5-3B6D-4E47-993D-97D0D0D6FD72Q28082135-FCC36F8E-7AAF-4723-BD4D-5F1BF01C4CE5Q28083303-F397888A-0AB0-4A4F-B34F-08EAD45E8480Q29307230-2C97A62B-0341-483B-A178-739F64C27FE2Q33419679-BEAA3F15-C391-4F5C-9C73-51531994D606Q33573503-AEE72714-848F-4470-97C9-D99AB9D606A0Q33660516-56DF2CB7-B215-4E1C-A08C-616542BD9997Q33820120-B45EA287-08B4-4377-844F-2EE6ED24B613Q33829778-4699248A-68C8-4FB3-AB26-7DC0AADA5892Q33945261-128F27BD-1D09-4F74-8211-E50540630E67Q33978891-DB8EA94E-21ED-494E-8021-09942E30EC5CQ34212939-F44F3235-BA1D-4559-8925-CDDA1DB6D782Q34392449-12350B71-D6EB-4C56-8324-5B5C8F13DAE8Q34431411-C4AE1E8C-8C4E-45C5-83E8-71F98BD633BFQ34451351-8EE1E4EF-DCB3-4D9D-8042-3D84777419D0Q34519678-D627B6DB-56E6-4A03-8060-98D1FACB3429Q34542826-15F52F68-2F09-457C-BF7F-3BD8D02954C5Q34645147-CB9C57F8-69B0-4D89-BCF7-00941306A973Q34649014-23D8954B-51DC-47D7-BD07-DADDC936CDFAQ35004982-FA2C0104-EFFE-4838-BD0F-DF8DA2308E66Q35112372-A60905F7-157F-4BD3-80A2-D87BF16DC8BEQ35252614-87D60236-AE23-42D3-ADF8-EB70D2A7EA98Q35298077-15DB8186-0C01-4F34-80F8-AFA80C0A7C53Q35633533-BB824B65-80ED-4402-8F09-5F034CFD504AQ35680392-88E38CC9-16EB-4B3A-89A8-F4666A9E2AE5Q35876974-CFB95E98-D38E-48DA-810F-173EA968AB6FQ36009002-D94780C0-5196-49C1-9D73-1BDC89A31D06Q36174878-C83FCB65-6ED0-4D5F-9F32-A15269923AD7Q36219790-B0313BC3-72DB-4849-B399-CE6394D25180Q36333552-DCE7A8DD-67E0-48D8-8BB8-0D5F46434740Q36337581-FD659D10-BEE7-423D-B0FD-829AFF1A8F69Q36492822-0D9257C7-8462-4ACB-ABFE-734A09F59BBEQ36958013-350C1A9B-222A-466E-9E02-D60E639C1919Q37091301-EA3E2078-83FF-44C3-878E-AD8B26A7F986Q37403322-8513CE78-5FEF-406E-A5C3-6CDD1B458CC2Q37880645-9F279617-A60F-43A3-B02D-4DEF334F756EQ37952705-6A359EA6-9646-4E55-A868-ED69082F0CF0Q38100685-CC0B5C48-EF10-4158-8DC9-A97083886518
P2860
Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of telomere length ...... val in severe aplastic anemia.
@en
Association of telomere length ...... val in severe aplastic anemia.
@nl
type
label
Association of telomere length ...... val in severe aplastic anemia.
@en
Association of telomere length ...... val in severe aplastic anemia.
@nl
prefLabel
Association of telomere length ...... val in severe aplastic anemia.
@en
Association of telomere length ...... val in severe aplastic anemia.
@nl
P2093
P2860
P356
P1476
Association of telomere length ...... ival in severe aplastic anemia
@en
P2093
Colin O Wu
Elaine M Sloand
James N Cooper
Neal S Young
P2860
P304
P356
10.1001/JAMA.2010.1376
P407
P577
2010-09-01T00:00:00Z